Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Merck secures tentative FDA approval for Lusduna
LUSDUNA Nexvue is being developed by Merck with funding from Samsung Bioepis. With the tentative approval, LUSDUNA Nexvue has met all required regulatory standards for follow-on biologics of
LUSDUNA Nexvue is being developed by Merck with funding from Samsung Bioepis. With the tentative approval, LUSDUNA Nexvue has met all required regulatory standards for follow-on biologics of
Top line data from this trial, being conducted in Italy, Israel, Greece and Turkey, is expected in Q4 2018. The primary objective of this multi-centre, multi-country and dose-ranging
These are the first data to demonstrate the potential to treat the underlying cause of CF in these patients, who have a severe and difficult-to-treat type of the
Raxibacumab is a fully human monoclonal antibody, which secured approval from the US Food and Drug Administration (FDA) for the treatment and prophylaxis of inhalational anthrax due to
The company’s latest report states that major drivers of the AML market will include the launch of premium-priced therapies, an increasing branded drug treatment rate, a growing desire
One of the important non-motor features of Parkinson’s disease is often the early presentation of severe and disabling impairment of gastrointestinal function. Parkinson’s disease is characterised by the
The label update is based on results from the ENSURE-AF study, the largest, prospective randomised clinical trial of an anticoagulant for cardioversion in patients with NVAF. The study
Limited partners of the Fund include industry veterans in other geographic markets, such as China Regenerative Medicine International Limited. "The sale of Obagi marks additional progress in our
Ciclesonides are included in the corticosteroids class of medications, and are approved to treat asthma (Alvesco) and allergic rhinitis (Omnaris and Zetonna). “We are excited to announce this
It comes after an open research competition led by the National Institute for Health Research (NIHR). Following the success of this initial competition, a call for a second